Abstract
BackgroundParkinson’s disease (PD) is one of the most common degenerative diseases of the central nervous system (CNS). Alpha-synuclein (A-syn) plays a critical role in the pathogenesis of PD. The close relation between the salivary glands and the CNS could render the A-syn secretions in the saliva useful biomarkers for PD.Aim of the workTo study the salivary A-syn levels in a cohort of PD Egyptian patients and to correlate these A-syn levels with the patients’ clinical data and disease severity.Patients and methodsTwenty-five PD patients and 15 age- and sex-matched healthy subjects, as a control group, were enrolled. Evaluation of PD patients was performed using the Unified Parkinson’s Disease Rating Scale (UPDRS) and modified Hoehn and Yahr scale (HYS). Samples of the saliva were analyzed using the enzyme-linked immunosorbent assay (ELISA) technique for the specific anti A-syn total and anti A-syn oligomer (A-synolig).ResultsThere was a statistically significant increase in A-synolig level and A-synolig/A-syn total ratio and a decrease in A-syn total level among PD patients. A statistically significant increase in A-synolig level was detected among patients having bradykinesia and rigidity as predominant symptoms. Also, there was a statistically significant positive correlation between A-synolig level and the disease duration. No statistically significant correlation was found between A-syn concentrations and disease severity.ConclusionSalivary A-syn total and A-synolig can be used as potential biomarkers for PD diagnosis.
Highlights
Parkinson’s disease (PD) is known to be the second most common neurodegenerative disease
A statistically significant increase in A-synolig level was detected among patients having bradykinesia and rigidity as predominant symptoms
Salivary A-syn total and A-synolig can be used as potential biomarkers for PD diagnosis
Summary
Parkinson’s disease (PD) is known to be the second most common neurodegenerative disease. It affects 1–2% of the population over the age of 60 [1]. Given its critical role in PD pathogenesis, alphasynuclein (A-syn) may be a useful biomarker [2]. A-syn is expressed in a monomeric form (A-synmon) [3]. In PD, A-synmon aggregates into A-syn oligomers (A-synolig) which in turn convert into mature amyloid fibrils, leading to the. Parkinson’s disease (PD) is one of the most common degenerative diseases of the central nervous system (CNS).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
